The curcumin market is expected to witness substantial growth by 2027 owing to rising awareness regarding curcumin’s health benefits among consumers globally. Moreover, increasing research focus on exploring the advantages of curcumin in pharmaceutical and medicinal applications is likely to fuel market expansion through the forecast period.

Curcumin, a naturally occurring phytochemical, is a substance present in turmeric. It offers a wide range of properties as an antioxidant, antimicrobial, anti-inflammatory, and antimutagenic molecule, which has immensely aided product adoption.

Curcumin has been used extensively as a medical herb in traditional Ayurvedic and Chinese medicine as a key element of natural remedies used for treating various pathologies, including diabetes, rheumatism, atherosclerosis, liver disease, and oncological and infectious illnesses.

Following the COVID-19 outbreak, studies have been exploring the significance of curcumin in treatment of the infection, which has positively impacted industry outlook. For instance, a May 2021 study published in the journal Frontiers of Pharmacology found that curcumin with piperine could be an effective adjuvant therapy for COVID-19 treatment. For the study, researchers utilized Curcumin C3 Complex, which is offered by East Windsor, NJ-based Sabinsa.

The findings of the study indicated that curcumin accelerated the symptomatic recovery of cough, sore throat, fever, and breathlessness, showed fewer incidences of red flag signs, resulted in less deterioration during hospitalization, and improved the ability to maintain an above 94% oxygen saturation on room air during hospital stay.

Additionally, industry players are developing innovative products to increase their consumer reach in the global marketplace, which has enhanced the business landscape. For instance, in July 2021, Pharma Way North America, a pharmaceutical firm based in Atlanta, launched DOT SHOT - a first-of-its-kind ultra-soluble curcumin wellness drink.

At the heart of the product is its proprietary dispersion technology that enables superfast body absorption of curcumin, which is an active ingredient in turmeric. As a result, mounting availability of novel products is boosting market growth across the globe.

For comprehensive assessment, the market has been segregated based on application and region. From the application perspective, the market has further been divided into food, pharmaceutical, cosmetics, and others (solar PV and textile industry). The pharmaceutical application segment is estimated to account for more than 50% of the curcumin market by the end of 2027, growing at a notable CAGR through the assessment period.

In the regional landscape, Latin America held around 3.5% share in the overall market in 2020 and is anticipated to expand at a considerable pace through the projected timeline. Meanwhile, the Middle East & Africa curcumin market is calculated to garner a respectable valuation by the end of 2027, progressing at a CAGR of approximately 9.5% through the forecast timeframe. Surging demand for organic & natural ingredients in the region is speculated to foster product demand in the coming years.